Trials / Completed
CompletedNCT03181594
Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis
Clinical Evaluation of Safety and Efficacy for the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Arrinex, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, prospective, non-randomized, interventional clinical trial to assess the safety and effectiveness of the ClariFix™ device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClariFix Device | Cryoablation in the nasal passageway using the ClariFix Device |
Timeline
- Start date
- 2017-03-02
- Primary completion
- 2018-07-31
- Completion
- 2020-04-06
- First posted
- 2017-06-09
- Last updated
- 2021-03-17
- Results posted
- 2019-11-04
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03181594. Inclusion in this directory is not an endorsement.